INTENSITY THERAPEUTICS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Research and development | $6.8M | $10.5M | $4.8M | $5.1M | — |
| Operating expenses | $12.0M | $16.6M | $8.3M | $7.5M | — |
| Operating income | -$12.0M | -$16.6M | -$8.3M | -$7.5M | — |
| Interest expense | — | $0 | $305,000 | $82,000 | — |
| Income tax expense | $0 | $0 | $0 | $0 | — |
| Net income | -$11.6M | -$16.3M | -$10.5M | -$7.6M | — |
| Balance Sheet | |||||
| Cash and equivalents | $11.9M | $2.6M | $8.6M | $1.3M | — |
| Current assets | $12.7M | $3.4M | $15.5M | $1.5M | — |
| Total assets | $14.1M | $4.8M | $17.3M | $1.8M | — |
| Current liabilities | $2.1M | $1.8M | $4.0M | $6.8M | — |
| Total liabilities | $2.2M | $1.9M | $4.1M | $6.9M | — |
| Stockholders' equity | $11.9M | $2.9M | $13.2M | -$15.1M | -$8.7M |
| Cash Flow Statement | |||||
| Cash from operations | -$9.2M | -$15.2M | -$7.2M | -$5.5M | — |
| Stock-based compensation | $2.0M | $3.1M | $1.4M | $1.2M | — |
Shares outstanding 2.7M · Free float 9.4%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.